Group 1 - The core point of the article highlights the performance and holdings of the Fuqua Precision Medical Mixed A fund, which has shown a recent decline in net value but strong returns over various time frames [1] - As of May 26, 2025, the latest net value of the fund is 2.8398 yuan, reflecting a decrease of 1.76%. The fund's one-month return is 1.98%, six-month return is 20.94%, and year-to-date return is 27.44% [1] - The fund's top ten stock holdings account for a total of 69.71%, with significant positions in companies such as Baillie Gifford (9.66%), Haisco (9.65%), and Kelun Pharmaceutical (9.10%) [1] Group 2 - The Fuqua Precision Medical Mixed A fund was established on November 16, 2017, and as of March 31, 2025, it has a total scale of 3.746 billion yuan [1] - The fund manager, Zhao Wei, has extensive experience in the pharmaceutical and investment sectors, having held various positions in companies such as GlaxoSmithKline and China Merchants Fund Management [2]
5月26日富国精准医疗混合A净值下跌1.76%，近1个月累计上涨1.98%
Sou Hu Cai Jing·2025-05-26 13:02